semaglutide for minors Effective Weight Loss in Adolescents: STEP TEENS Teen Weight Loss & Semaglutide:

FDA Approval and Intended Use Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) are specifically FDA-approved for chronic weight management in adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition

Theyre considered to be long-term medications because they are treating a chronic condition of overweight or obesity, says Lofton

All of those things can potentially result in symptoms, he said

Although this medication is not yet FDA-approved for the treatment of obesity, it was granted fast track designation for this indication in October 2022 and current results look promising

Notes: Do not exceed 1g/weekly

Step 3: Track how you feel